Clinical Trial Update: COREG MR Versus TOPROL-XL On The Lipid Profile Of Normolipidemic Or Mildly Dyslipidemic Patients With Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial comparing COREG MR to TOPROL-XL on lipid profiles in normolipidemic or mildly dyslipidemic patients with hypertension. The study results were post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hypertension

Drugs mentioned

• COREG MR (carvedilol)
• TOPROL XL (METOPROLOL SUCCINATE)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2010-02-01